Clinical Trial Update: Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients [NA]

View source ↗

Summary

Clinical trial update on combining the NaviFUS System with re-irradiation for recurrent glioblastoma and high-grade glioma (WHO III–IV); the study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• NaviFUS System

Snippet

Sponsor: NaviFUS Corporation | Conditions: Recurrent Glioblastoma, High-Grade Glioma (WHO III-IV) | NA | Status: COMPLETED